rs1060502608
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP2PP3_ModeratePP5_Moderate
The NM_005184.4(CALM3):c.281A>C(p.Asp94Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
CALM3
NM_005184.4 missense
NM_005184.4 missense
Scores
12
3
1
Clinical Significance
Conservation
PhyloP100: 9.21
Genes affected
CALM3 (HGNC:1449): (calmodulin 3) This gene encodes a member of a family of proteins that binds calcium and functions as a enzymatic co-factor. Activity of this protein is important in the regulation of the cell cycle and cytokinesis. Multiple alternatively spliced transcript variants have been observed at this gene. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PM1
In a binding_site (size 0) in uniprot entity CALM3_HUMAN
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CALM3. . Gene score misZ 2.9788 (greater than the threshold 3.09). Trascript score misZ 3.6287 (greater than threshold 3.09). GenCC has associacion of gene with long QT syndrome, familial long QT syndrome, long QT syndrome 16, catecholaminergic polymorphic ventricular tachycardia.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.931
PP5
Variant 19-46608584-A-C is Pathogenic according to our data. Variant chr19-46608584-A-C is described in ClinVar as [Pathogenic]. Clinvar id is 409871.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CALM3 | NM_005184.4 | c.281A>C | p.Asp94Ala | missense_variant | 4/6 | ENST00000291295.14 | NP_005175.2 | |
LOC124904729 | XR_007067276.1 | n.485T>G | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CALM3 | ENST00000291295.14 | c.281A>C | p.Asp94Ala | missense_variant | 4/6 | 1 | NM_005184.4 | ENSP00000291295 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Long QT syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 18, 2022 | ClinVar contains an entry for this variant (Variation ID: 409871). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This missense change has been observed in individual(s) with clinical features of CALM3-related conditions (Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 94 of the CALM3 protein (p.Asp94Ala). - |
not provided Pathogenic:1
Likely pathogenic, no assertion criteria provided | provider interpretation | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Jan 25, 2018 | Found in an 8-year-old female with a recent history of sudden cardiac arrest. p.Asp94Ala (D94A; c.281A>C) in exon 4 of the CALM3 gene (NM_005184.2) Chromosome position: 19:47111841 A / C Based on the information reviewed below, we classify this variant as Likely Disease Causing, concluding that there is sufficient evidence for its pathogenicity to warrant using it for predictive genetic testing in at-risk family members. This variant is novel and has not been reported in the biomedical literature. However, this gene was only recently associated with sudden cardiac arrest in infants and young children. Clinical genetic testing has been available for CALM3 for only a few years, and very few variants have been reported. Specifically, there are only 4 Likely Pathogenic or Pathogenic missense variants listed in ClinVar as of 1/25/2018. This is one of three genes that code for human calmodulin (CALM1, CALM2, and CALM3), which produce proteins with identical amino acid sequences. The vast majority of reportedly pathogenic variants in these genes, thus far, have been de novo in children with cardiac arrest. The Asp94Ala variant is de novo in our affected patient with cardiac arrest at age 8, and we consider this convincing evidence of pathogenicity. The papers to date involving CALM1-3 indicate that the pathogenic mutations are located in one of the four “EF-hands†(calcium-binding loops) in the protein, specifically at residues that interact with and bind calcium. Our patient’s variant is in calcium-binding loop III, and it modifies an Aspartic Acid that interacts directly with calcium: p.Asp94Ala. It is adjacent to other reported disease-causing variants in CALM1, CALM2, or CALM3, which all form an identical calmodulin protein product, from the recent papers (Asp96Val, Asn98Ser, Asn98Ile), some of which have been reported more than once (references: Nyegaard et al. 2012; Crotti et al. 2013; Makita et al. 2014; Boczek et al. 2016). This is a nonconservative amino acid change, resulting in the replacement of a negatively-charged Aspartic Acid with a nonpolar Alanine. Aspartic Acid at this location is absolutely conserved across vertebrate species, and surrounding residues are also highly conserved. Calmodulin has a constraint metric of z = 2.92 in ExAC, indicating that missense variation is not well-tolerated (9 missense variant observed, with 52 expected). Variation at nearby residues of calmodulin has been associated with sudden cardiac arrest in infants and young children, which supports the functional importance of this region of the protein. Invitae reports that in-silico algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, although these predictions have not been confirmed by published functional studies. As of 1/25/2018, this variant is absent from the gnomAD database, which includes variant calls on ~140,000 individuals of European, African, Latino, South Asian, Ashkenazi, and East Asian descent. There is good coverage at this site. The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. The curators made an effort to exclude individuals with severe pediatric diseases. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;.;.;.;D;.
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
.;D;.;.;.;.
REVEL
Pathogenic
Sift4G
Uncertain
D;D;D;D;D;D
Vest4
MutPred
0.73
.;Loss of stability (P = 0.0133);.;.;.;Loss of stability (P = 0.0133);
MVP
MPC
3.0
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at